skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: These stocks were mentioned in the article about possible TSX graduates. Knowing they are small caps, could you comment on them and rank them. Are any of them a buy at this time. Thanks
Read Answer Asked by Bruce on November 25, 2021
Q: You found some microcaps interesting years ago and I'm wondering if you still like some of them and/or perhaps there are others you like for a 5-10 year hold?

Read Answer Asked by Gregory on May 04, 2021
Q: Similar question to the one I asked yesterday. This is regarding some small/medium sized consumer and consumer-related type Canadian stocks. How would you feel about holding each of these stocks in your portfolio, on a 1-10 scale, with a 10 being you definitely want the stock in your portfolio, a 1 being a stock you want no part of, and a 5 being a stock you are basically indifferent about. As part of broadly diversified portfolio, looking for total return over the next 5+ years, comfortable with risk. ACQ, AW.UN, DOO, ECN, GOOS, HTL, LNF, MTY, SIS, SVI, ZZZ.
Read Answer Asked by Dan on March 12, 2021
Q: Hello, can I please get your general opinion, as well as comments on recent earnings for the following small caps: HTL, CLIQ, AND, MVP
Read Answer Asked by Philip on August 25, 2020
Q: Hi,
I have a few questions.
1) BAM is still about 50% off its February high. Why is that, given that so many other stocks have recovered considerably more? What is your opinion of it as a long-term investment? What about BEP?
2) What is your opinion of MIC as a long-term investment? Does it at least merit a “hold” at present?
3) How likely is it that the following small-caps will survive the present crisis: PL, HTL, ENW, VFF and PILL.CN?
Read Answer Asked by Camille on April 28, 2020
Q: Thoughts on the earnings released this morning?

Sales increased 21% to $35.4 million for the year-ended December 31, 2019; up 34% to $10.8 million for the fourth quarter; Sales in constant currency increased 24% for the year; 36% for the quarter.

Gross profit increased 15% to $19.0 million for the year; up 34% to $6.1 million for the quarter.

Net income of $793 thousand for the year and $931 thousand for the quarter.

Adjusted EBITDA increased 15% year over year to $7.1 million for the year; up 28% to $2.2 million for the quarter.

Organic growth was 12% for the year; 15% in constant currency. Organic growth was 17% for the quarter, 18% in constant currency.

Cash flow from operations was $6.4 million for the year, up 48%, and total cash at December 31, 2019 was $12.8 million.
Read Answer Asked by Kevin on April 23, 2020
Q: While you have not been particularly enthusiastic to this point, I would appreciate your analysis of their latest results. Clearly the market was very impressed as it cracked both the highest gainers and most heavily traded lists yesterday.

BEVERLY, Mass. and TORONTO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year ended December 31, 2019.

Based on preliminary unaudited results, 2019 revenues increased 21% to a record $35.3 million with adjusted EBITDA for the year of approximately $7.1 million (14.6% year over year growth). Fourth quarter sales increased 34% to $10.8 million, with adjusted EBITDA estimated to increase 27% to approximately $2.2 million. Organic growth on a constant currency basis was approximately 15% for the year and approximately 20% in the fourth quarter, largely driven by sales increases of equipment and consumables. Gross profit margins were approximately 53.8% for the year and 56.4% for the fourth quarter.
Read Answer Asked by karl on February 20, 2020
Q: Hi 5i Team,

I have partial positions in both of the 2 stocks above and I am looking at adding to one of them. I've had HTL for awhile and has climbed back to my purchase price and trending nicely even with recent volatility. TCS is a relatively new position for me. I've watched it for a while and missed the initial run I really like its potential. Both are part of a diversified small cap portfolio.

I would like to know if you would be comfortable adding to positions in these stocks today? Do you have a preference for one or the other today?

Many Thanks and have a great day!
Read Answer Asked by Colin on January 29, 2020
Q: Another service really likes fertility company Hamilton Thorne and has made it a recommendation. Progyny in the US seems to be doing well in a related business so I wanted your thoughts. With people marrying later the theme seems to make sense. Do you like it? A brief example of the write is up below. They write interesting stuff but don't have your track record so I'd love to know what 5i thinks.

When we recommended Hamilton Thorne back in August, we believed the strategy for growth was three-pronged, involving both acquisitions and organic opportunity as well as margin improvement along the way. Recent results fully support our belief, and we’re firmly of the mind that we’re nicely on track.
Read Answer Asked by Tim on January 13, 2020